Cures, jobs, ethics on the line in vote on stem cell research
By Megha Satyanarayana,
Detroit Free Press
| 09. 24. 2008
Opposing sides dig in as vote nears on Proposal 2
Ryan Dinkgrave lived a carefree life in Livonia until he was diagnosed with type I diabetes at age 10. Suddenly everything was ordered and careful.
"It makes you rethink everything you do," he said. "You're young, you're told you need to do shots, you're measuring your blood sugar. You have to count, carefully measure everything you eat."
Dinkgrave, now 25 and of Royal Oak, is among Michigan residents who support Proposal 2, a November ballot initiative allowing Michigan researchers to make embryonic stem cell cultures from excess embryos donated from fertility treatments. Researchers say the cells could unlock the secrets of disease and lead to cures for illnesses such as Alzheimer's and type I diabetes.
Voters will decide this emotionally charged issue on the basis of a 100-word ballot initiative -- one that could not only affect people's health, but also the economy of Michigan for decades to come. Proponents say the measure could spark a life sciences sector and pump billions of dollars into the state's struggling economy.
Opponents insist embryonic stem cell research is unnecessary because alternative types...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...